People In The News

NEW YORK (GenomeWeb News) – Molecular diagnostics and cytology test developer Veracyte said this week that it has named Shelly Guyer to be its chief financial officer.

Guyer formerly was CFO and executive VP of finance and administration at iRhythm Technologies, and she was VP of business development and investor relations at the biotech firm Nuvelo. She also spent 17 years at JP Morgan Securities and its predecessor companies, where she led financing for large- and small-cap life sciences firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.